Foresee Pharmaceuticals Co Stock Current Valuation
| 6576 Stock | TWD 77.70 0.10 0.13% |
Valuation analysis of Foresee Pharmaceuticals helps investors to measure Foresee Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Foresee Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Foresee Pharmaceuticals is based on 3 months time horizon. Increasing Foresee Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Foresee stock is determined by what a typical buyer is willing to pay for full or partial control of Foresee Pharmaceuticals Co. Since Foresee Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Foresee Stock. However, Foresee Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 77.7 | Real 65.25 | Hype 77.7 |
The intrinsic value of Foresee Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Foresee Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Foresee Pharmaceuticals Co helps investors to forecast how Foresee stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Foresee Pharmaceuticals more accurately as focusing exclusively on Foresee Pharmaceuticals' fundamentals will not take into account other important factors: Foresee Pharmaceuticals Co Company Current Valuation Analysis
Foresee Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Foresee Pharmaceuticals Current Valuation | 10.39 B |
Most of Foresee Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Foresee Pharmaceuticals Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Foresee Pharmaceuticals Co has a Current Valuation of 10.39 B. This is 27.67% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Taiwan stocks is 37.51% higher than that of the company.
Foresee Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Foresee Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Foresee Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Foresee Pharmaceuticals by comparing valuation metrics of similar companies.Foresee Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Foresee Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | (1.57) % | |||
| Operating Margin | (1.57) % | |||
| Current Valuation | 10.39 B | |||
| Shares Outstanding | 118.12 M | |||
| Shares Owned By Insiders | 35.40 % | |||
| Shares Owned By Institutions | 3.14 % | |||
| Price To Book | 10.24 X | |||
| Price To Sales | 39.29 X | |||
| Revenue | 226.03 M | |||
| Gross Profit | 175.08 M | |||
| EBITDA | (475.83 M) | |||
| Net Income | (569.27 M) | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 11.47 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 18.76 X | |||
| Book Value Per Share | 9.36 X | |||
| Cash Flow From Operations | (213.33 M) | |||
| Earnings Per Share | (4.53) X | |||
| Target Price | 110.0 | |||
| Number Of Employees | 29 | |||
| Beta | 1.42 | |||
| Market Capitalization | 12.58 B | |||
| Total Asset | 1.64 B | |||
| Net Asset | 1.64 B |
About Foresee Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Foresee Pharmaceuticals Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Foresee Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Foresee Pharmaceuticals Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Foresee Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Foresee Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Foresee Stock
Moving against Foresee Stock
| 0.75 | 2881A | Fubon Financial Holding | PairCorr |
| 0.74 | 2850 | Shinkong Insurance | PairCorr |
| 0.72 | 2882B | Cathay Financial Holding | PairCorr |
| 0.66 | 2883B | CHINA DEVELOPMENT | PairCorr |
| 0.64 | 2454 | MediaTek | PairCorr |
The ability to find closely correlated positions to Foresee Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Foresee Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Foresee Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Foresee Pharmaceuticals Co to buy it.
The correlation of Foresee Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Foresee Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Foresee Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Foresee Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.